See more : Xbrane Biopharma AB (publ) (XBRANE.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Cloud DX Inc. (CDXFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cloud DX Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Minerva Intelligence Inc. (MVAIF) Income Statement Analysis – Financial Results
- Taiwan Semiconductor Manufacturing Company Limited (TSM) Income Statement Analysis – Financial Results
- Johnson Electric Holdings Limited (0179.HK) Income Statement Analysis – Financial Results
- Unity Opto Technology Co., Ltd. (2499.TW) Income Statement Analysis – Financial Results
- Maxvision Technology Corp. (002990.SZ) Income Statement Analysis – Financial Results
Cloud DX Inc. (CDXFF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.clouddx.com
About Cloud DX Inc.
Cloud DX Inc. operates as a remote patient monitoring company. It offers Cloud DX Connected Health, an end-to-end virtual healthcare platform for monitoring patients with chronic illness, including chronic obstructive pulmonary disease and congestive heart failure, as well as patients recovering from surgery and COVID-19 patients outside hospitals. The company's Cloud DX Connected Health Kits includes its Cloud DX Bluetooth pulse oximeter, the Cloud DX wireless weight scale and optionally, a wireless Bluetooth blood pressure monitor, digital thermometer, and digital wireless glucose meter from 3rd party suppliers. It serves academic institutions, large hospitals, and provincial health authorities in Canada, as well as physician practices and hospitals in the United States. The company also offers VITALITI, a vital sign monitor for measuring electrocardiograph, heart rate, oxygen saturation, respiration, core body temperature, blood pressure, movement, steps, and posture. Cloud DX Inc. is headquartered in Brooklyn, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.81M | 1.17M | 782.30K | 1.16M | 1.25M | 247.77K |
| Cost of Revenue | 529.21K | 563.11K | 491.29K | 732.60K | 228.17K | 127.76K |
| Gross Profit | 1.28M | 602.90K | 291.01K | 431.20K | 1.02M | 120.01K |
| Gross Profit Ratio | 70.79% | 51.71% | 37.20% | 37.05% | 81.76% | 48.44% |
| Research & Development | 192.99K | 397.93K | 473.88K | 550.52K | 252.57K | 317.86K |
| General & Administrative | 6.90M | 9.11M | 9.34M | 5.97M | 842.16K | 1.08M |
| Selling & Marketing | 252.73K | 312.08K | 468.63K | 116.35K | 153.70K | 159.75K |
| SG&A | 7.15M | 9.43M | 9.80M | 6.08M | 287.20K | 6.44M |
| Other Expenses | 1.67M | -18.79K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 9.02M | 9.83M | 9.48M | 5.58M | 287.20K | 7.03M |
| Cost & Expenses | 9.55M | 10.39M | 9.97M | 6.31M | 287.20K | 7.16M |
| Interest Income | 0.00 | 1.60M | 709.40K | 732.23K | 336.99K | 224.11K |
| Interest Expense | 3.37M | 1.60M | 709.40K | 732.23K | 0.00 | 0.00 |
| Depreciation & Amortization | 477.96K | 498.77K | 407.95K | 340.14K | 164.51K | 168.72K |
| EBITDA | -6.93M | -8.79M | -10.24M | -4.74M | -4.40M | -6.82M |
| EBITDA Ratio | -382.42% | -748.52% | -1,122.64% | -412.98% | -22.96% | -2,751.18% |
| Operating Income | -7.74M | -9.72M | -10.42M | -6.55M | -287.20K | -6.99M |
| Operating Income Ratio | -426.90% | -833.54% | -1,332.04% | -562.81% | -22.96% | -2,819.27% |
| Total Other Income/Expenses | -3.04M | -1.17M | -934.58K | 737.73K | -4.68M | -146.18K |
| Income Before Tax | -10.78M | -10.89M | -11.36M | -5.81M | -312.20K | -7.13M |
| Income Before Tax Ratio | -594.93% | -934.04% | -1,451.51% | -499.42% | -24.95% | -2,878.27% |
| Income Tax Expense | -433.91K | -273.89K | -98.22K | 732.31K | -164.51K | 0.00 |
| Net Income | -10.35M | -10.62M | -11.26M | -5.81M | -312.20K | -7.13M |
| Net Income Ratio | -570.99% | -910.55% | -1,438.95% | -499.42% | -24.95% | -2,878.27% |
| EPS | -0.11 | -0.15 | -0.18 | -0.67 | -0.27 | -5.39 |
| EPS Diluted | -0.11 | -0.15 | -0.18 | -0.67 | -0.27 | -5.39 |
| Weighted Avg Shares Out | 93.13M | 72.09M | 64.28M | 8.73M | 1.14M | 1.32M |
| Weighted Avg Shares Out (Dil) | 93.13M | 72.09M | 64.28M | 8.73M | 1.14M | 1.32M |
Cloud DX Signs 3 Contracts for Remote Patient Monitoring with Combined Value of approx. $375,000 CAD
Cloud DX contract expected to generate more business in coming quarters: CEO
Cloud DX inks C$115K plus contract to design vital signs wearable
Cloud DX Signs 6-Figure Contract to Design New Wearable; Company Will Present at a Webinar and 4 Investor Conferences
Cloud DX secures new contract with Health PEI for remote patient monitoring
Cloud DX Signs Contract with Health PEI to Provide Remote Patient Monitoring
Cloud DX Announces Closing of $1,942,000 Private Placement of Convertible Debenture Units, Amendments to Existing Secured Convertible Securities, and Equity Incentive Grants
Cloud DX announces changes to debenture financing, including new placement and debt settlement agreement
Cloud DX Announces Amendments to Private Placement of Secured Convertible Debentures, $2.5 Million Private Placement of Convertible Debenture Units, and Debt Settlement Agreement
Cloud DX sees year to date revenue surge on contracts performance
Source: https://incomestatements.info
Category: Stock Reports